There are several other mechanisms that could account for the effect of DM on the risk of HCC in patients with chronic hepatitis C. First, insulin is a growth factor, and high insulin levels in patients with insulin resistance may interfere with the action of interferon, thereby decreasing both rapid and sustained virological responses [42, 74–76]. The gene discussed is INS; the disease is hepatocellular carcinoma.